PARP1 and ovarian carcinoma: The cleaved PARP-1 protein fraction was detected in the untreated ovarian cell lysates, with the presence of the enzyme being a characteristic of tumor cells and a therapeutic target for PARP-1 inhibitors in ovarian cancer.